Norges Bank’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-201,582
Closed -$19.7M 2351
2015
Q1
$19.7M Sell
201,582
-3,683
-2% -$359K 0.01% 1219
2014
Q4
$19M Buy
205,265
+14,676
+8% +$1.36M 0.01% 1244
2014
Q3
$13.1M Sell
190,589
-263,813
-58% -$18.1M 0.01% 1417
2014
Q2
$47.6M Buy
454,402
+227,201
+100% +$23.8M 0.01% 1060
2014
Q1
$18.9M Buy
227,201
+35,000
+18% +$2.9M 0.01% 1182
2013
Q4
$12.4M Hold
192,201
0.01% 1451
2013
Q3
$12.2M Buy
192,201
+87,321
+83% +$5.53M 0.01% 1444
2013
Q2
$4.41M Buy
+104,880
New +$4.41M ﹤0.01% 1903